Is Amgen A Good Stock To Buy (COMPLETE × 2024)

The market is hyper-focused on MariTide , Amgen’s monthly-dose obesity candidate, which could disrupt the current weekly-dose market dominated by Eli Lilly and Novo Nordisk.

Recent moves, such as the $840 million deal for Dark Blue Therapeutics, bolster its oncology pipeline in areas like acute myeloid leukemia (AML). The Bear Case is amgen a good stock to buy

Amgen's appeal lies in its ability to generate massive cash flow while aggressively pivoting its portfolio to offset upcoming biosimilar competition. The Bull Case The market is hyper-focused on MariTide , Amgen’s

Amgen (AMGN) currently presents as a for most investors, though it remains a top-tier choice for those seeking a mix of steady dividends and high-potential pipeline updates. As of late April 2026, the stock is navigating a transition from legacy blockbusters to next-generation therapies in obesity and oncology. Amgen Inc (AMGN) 30.22% since Jan 4, 2025 Closed: 23:00 • Disclaimer After hours: 03:00 Apr 27, 2026 Open342.35 Mkt cap$183.57B USD 52-wk high391.29 High348.04 P/E ratio23.91 52-wk low261.43 Div yield2.96% The Investment Thesis: Growth vs. Defense The Bull Case Amgen (AMGN) currently presents as

Racing Speed Simulator 3d

This game, like other games on our website, is provided free of charge legally, as it was licensed or sublicensed to us by a game developer or a game publisher, or was developed by our internal game development studio. Distribution and modification of this game and promotional materials without our permission is prohibited.